Marinomed Biotech AG

Marinomed Biotech AG is an Austrian biopharmaceutical company specializing in the development of innovative products based on IP protected technology platforms, such as Marinosolv® and Carragelose®. The Solv4U partnerships program addresses the challenge of hardly soluble APIs in drug development and relies on the clinically proven technology Marinosolv® by customized aqueous formulations, in order to improve the bioavailability and thereby therapeutic efficacy.